Technology - Cancer Currents Blog
News and commentaries on technology used to conduct cancer research, deliver cancer treatment, improve patient care, and screen for cancer, as well as other topics.
-
Genomic Profiling Tests Cleared by FDA Can Help Guide Cancer Treatment, Clinical Trial EnrollmentThe FDA has recently approved two tests to identify genetic alterations in tumors. One of the tests can be used to identify patients who may be candidates to receive specific targeted therapies.
-
Liquid Biopsy: Using DNA in Blood to Detect, Track, and Treat CancerResearch studies show tests that analyze tumor DNA in blood, called liquid biopsies, may help detect cancer early, guide precision cancer treatment, and track treatment response.
-
NCI Program Supports Small Businesses to Advance Cancer Research Innovation – A Q&A with Michael WeingartenNCI’s Small Business Innovation Research Program recently issued contract solicitations to spur the development of new cancer-related therapies and technologies, including seven opportunities specific to the Cancer Moonshot.
-
NCI’s Technology Transfer Center—Moving Inventions and Ideas from the Lab to Patients: An Interview with Dr. Michael SalgallerAn interview with Dr. Michael Salgaller about how NCI’s Technology Transfer Center helps to move new technologies developed by NCI and NIH scientists from the lab to the bedside.
-
Introducing DAVE: Online Analysis Tools for the Genomic Data CommonsNCI has released an online, open-access cancer research resource for the Genomic Data Commons called the Data Analysis, Visualization, and Exploration Tools, or DAVE.
-
Advancing the Potential and Promise of Total-Body PET ImagingA total-body PET scanner under development is an ideal example of how NCI and NIH are supporting the development of new research and cancer care-related technologies.
-
NCTN/NCORP Data Archive: Expanding Access to Clinical Trial DataNCI is launching the NCTN/NCORP Data Archive, a centralized repository of patient-level data from phase III clinical trials conducted by NCI’s NCTN and NCORP trials programs and the National Cancer Institute of Canada-Clinical Trials Group.
-
Single Tumor Cells Reveal Clues to Biology of Multiple MyelomaA study suggests that individual tumor cells circulating in the blood of patients with multiple myeloma may be a new source of information about the genetic changes driving the disease.
-
Device Uses Cancer Cells' Mass to Predict Response to TreatmentScientists have designed a device that measures the mass of single cancer cells to predict how cells respond to drug treatment. The technology could potentially help clinicians determine whether a drug effectively kills cancer cells.
-
Connected Health: An Important Tool for Making Progress against Cancer
A new report from the President’s Cancer Panel outlines how connective technologies can promote cancer prevention, enhance patients’ treatment experience, and accelerate progress in cancer research.
-
Meeting Patients Where They Are: Liberating Clinical Trials Data Under the Cancer MoonshotNCI’s new application programming interface (API) that allows anyone to build online tools that help people find NCI-supported clinical trials.
-
Engineered Stem Cells Help Identify Potential New Treatment for MedulloblastomaStem cells engineered to mimic medulloblastoma development may help researchers identify potential new treatments, according to a new study.
-
Tumor DNA in Blood May Signal Response to T-Cell Transfer ImmunotherapyA study suggests that doctors could use circulating tumor DNA to quickly identify patients who are responding to T-cell transfer immunotherapy.
-
Nanoparticle that Mimics Salmonella Counteracts Chemotherapy ResistanceA nanoparticle that mimics Salmonella may help to counteract chemotherapy resistance, according to a new study.
-
Nanoparticle Delivers Cancer Drugs to Tumor Blood VesselsIn cancer mouse models, nanoparticles that bind to a protein called P-selectin on tumor blood vessels shrank tumors and extended survival.
-
Blood Test for Genetic Changes in Tumors Shows Promise as Alternative to Tumor BiopsyThe largest study of its kind to date has shown that a test that assesses DNA mutations and other changes in genetic material shed from tumors into the blood—a liquid biopsy—produced results highly similar to those of traditional tumor biopsies.
-
Calling on Data Enthusiasts to Help Advance Cancer ResearchHealth data enthusiasts of all stripes were in Washington, D.C., today for Health Datapalooza. NCI's Dr. Warren Kibbe explains that this annual event explores a topic that is central to NCI’s efforts against cancer: creating knowledge from data.
-
Targeted Photoimmunotherapy Approach for Cancer Moves ForwardTwo new studies from NCI researchers add to growing evidence of the promise of a novel type of cancer immunotherapy that uses infrared light to activate rapid and selective killing of cancer cells.
-
Nanoparticle Generator Slips Chemotherapy Past Tumor Cells’ Protective BarriersResearchers have developed a new injectable nanoparticle-generating technology that can deliver a cancer drug to the nucleus of metastatic breast cancer cells.
-
High-Magnification Microscopy Visualizes Tumor Blood Vessels in Real TimeHigh-powered intravital microscopy reveals that 50 percent of blood vessels in melanoma tumors do not have any blood flow, according to a new study.